Glycyrrhizin (Gly) is thought to protect against brain damage induced by ischaemic stroke by inhibiting the activation of CD8+ and CD4+ T cells mediated by IFN and partly regulated by HMGB1 activity [147]. This evidence concerns the gene CD8A and ischemic stroke.